vs
Side-by-side financial comparison of Organon & Co. (OGN) and SEALED AIR CORP (SEE). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.4B, roughly 1.1× SEALED AIR CORP). SEALED AIR CORP runs the higher net margin — 3.1% vs -13.6%, a 16.7% gap on every dollar of revenue. On growth, SEALED AIR CORP posted the faster year-over-year revenue change (2.6% vs -5.3%). SEALED AIR CORP produced more free cash flow last quarter ($257.7M vs $96.0M). Over the past eight quarters, SEALED AIR CORP's revenue compounded faster (2.7% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
Sealed Air Corporation is a global provider of innovative packaging and protective solutions. Its core offerings include cushioning materials, food safety and preservation packaging, and sustainable waste-reducing packaging systems, serving retail, e-commerce, food and beverage, and industrial manufacturing markets worldwide.
OGN vs SEE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.4B |
| Net Profit | $-205.0M | $43.8M |
| Gross Margin | 49.2% | 28.6% |
| Operating Margin | -9.8% | 11.4% |
| Net Margin | -13.6% | 3.1% |
| Revenue YoY | -5.3% | 2.6% |
| Net Profit YoY | -288.1% | 700.0% |
| EPS (diluted) | $-0.78 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $1.4B | ||
| Q3 25 | $1.6B | $1.3B | ||
| Q2 25 | $1.6B | $1.3B | ||
| Q1 25 | $1.5B | $1.3B | ||
| Q4 24 | $1.6B | $1.4B | ||
| Q3 24 | $1.6B | $1.3B | ||
| Q2 24 | $1.6B | $1.3B | ||
| Q1 24 | $1.6B | $1.3B |
| Q4 25 | $-205.0M | $43.8M | ||
| Q3 25 | $160.0M | $255.1M | ||
| Q2 25 | $145.0M | $93.1M | ||
| Q1 25 | $87.0M | $113.5M | ||
| Q4 24 | $109.0M | $-7.3M | ||
| Q3 24 | $359.0M | $91.7M | ||
| Q2 24 | $195.0M | $98.3M | ||
| Q1 24 | $201.0M | $82.0M |
| Q4 25 | 49.2% | 28.6% | ||
| Q3 25 | 53.5% | 29.8% | ||
| Q2 25 | 54.8% | 30.7% | ||
| Q1 25 | 55.6% | 30.9% | ||
| Q4 24 | 56.3% | 30.0% | ||
| Q3 24 | 58.3% | 30.1% | ||
| Q2 24 | 58.4% | 31.2% | ||
| Q1 24 | 59.0% | 30.3% |
| Q4 25 | -9.8% | 11.4% | ||
| Q3 25 | 15.2% | 13.8% | ||
| Q2 25 | 14.4% | 15.0% | ||
| Q1 25 | 6.7% | 14.5% | ||
| Q4 24 | 8.1% | 11.7% | ||
| Q3 24 | 13.1% | 13.9% | ||
| Q2 24 | 14.6% | 15.4% | ||
| Q1 24 | 14.5% | 14.0% |
| Q4 25 | -13.6% | 3.1% | ||
| Q3 25 | 10.0% | 19.0% | ||
| Q2 25 | 9.1% | 7.0% | ||
| Q1 25 | 5.8% | 9.0% | ||
| Q4 24 | 6.8% | -0.5% | ||
| Q3 24 | 22.7% | 6.9% | ||
| Q2 24 | 12.1% | 7.4% | ||
| Q1 24 | 12.4% | 6.2% |
| Q4 25 | $-0.78 | $0.30 | ||
| Q3 25 | $0.61 | $1.73 | ||
| Q2 25 | $0.56 | $0.63 | ||
| Q1 25 | $0.33 | $0.77 | ||
| Q4 24 | $0.42 | $-0.05 | ||
| Q3 24 | $1.38 | $0.63 | ||
| Q2 24 | $0.75 | $0.67 | ||
| Q1 24 | $0.78 | $0.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $344.0M |
| Total DebtLower is stronger | $8.6B | $3.3B |
| Stockholders' EquityBook value | $752.0M | $1.2B |
| Total Assets | $12.9B | $7.0B |
| Debt / EquityLower = less leverage | 11.49× | 2.65× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $574.0M | $344.0M | ||
| Q3 25 | $672.0M | $282.5M | ||
| Q2 25 | $599.0M | $354.4M | ||
| Q1 25 | $547.0M | $335.2M | ||
| Q4 24 | $675.0M | $371.8M | ||
| Q3 24 | $763.0M | $386.0M | ||
| Q2 24 | $704.0M | $388.6M | ||
| Q1 24 | $575.0M | $352.8M |
| Q4 25 | $8.6B | $3.3B | ||
| Q3 25 | $8.8B | $4.0B | ||
| Q2 25 | $8.9B | $4.0B | ||
| Q1 25 | $9.0B | $4.2B | ||
| Q4 24 | $8.9B | $4.2B | ||
| Q3 24 | $8.7B | $4.3B | ||
| Q2 24 | $8.7B | $4.4B | ||
| Q1 24 | $8.7B | $4.5B |
| Q4 25 | $752.0M | $1.2B | ||
| Q3 25 | $906.0M | $1.2B | ||
| Q2 25 | $733.0M | $953.1M | ||
| Q1 25 | $542.0M | $797.9M | ||
| Q4 24 | $472.0M | $624.5M | ||
| Q3 24 | $493.0M | $771.2M | ||
| Q2 24 | $144.0M | $650.1M | ||
| Q1 24 | $48.0M | $598.3M |
| Q4 25 | $12.9B | $7.0B | ||
| Q3 25 | $13.6B | $7.1B | ||
| Q2 25 | $13.5B | $7.2B | ||
| Q1 25 | $13.2B | $7.0B | ||
| Q4 24 | $13.1B | $7.0B | ||
| Q3 24 | $12.8B | $7.3B | ||
| Q2 24 | $12.2B | $7.3B | ||
| Q1 24 | $11.9B | $7.2B |
| Q4 25 | 11.49× | 2.65× | ||
| Q3 25 | 9.74× | 3.34× | ||
| Q2 25 | 12.14× | 4.18× | ||
| Q1 25 | 16.52× | 5.26× | ||
| Q4 24 | 18.81× | 6.72× | ||
| Q3 24 | 17.75× | 5.62× | ||
| Q2 24 | 60.11× | 6.81× | ||
| Q1 24 | 181.54× | 7.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | $293.6M |
| Free Cash FlowOCF − Capex | $96.0M | $257.7M |
| FCF MarginFCF / Revenue | 6.4% | 18.5% |
| Capex IntensityCapex / Revenue | 3.0% | 2.6% |
| Cash ConversionOCF / Net Profit | — | 6.70× |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | $458.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.0M | $293.6M | ||
| Q3 25 | $264.0M | $165.9M | ||
| Q2 25 | $220.0M | $136.6M | ||
| Q1 25 | $75.0M | $31.9M | ||
| Q4 24 | $390.0M | $244.2M | ||
| Q3 24 | $141.0M | $170.5M | ||
| Q2 24 | $332.0M | $188.2M | ||
| Q1 24 | $76.0M | $125.1M |
| Q4 25 | $96.0M | $257.7M | ||
| Q3 25 | $218.0M | $119.6M | ||
| Q2 25 | $181.0M | $93.2M | ||
| Q1 25 | $43.0M | $-12.0M | ||
| Q4 24 | $335.0M | $185.1M | ||
| Q3 24 | $99.0M | $115.2M | ||
| Q2 24 | $300.0M | $129.5M | ||
| Q1 24 | $30.0M | $78.0M |
| Q4 25 | 6.4% | 18.5% | ||
| Q3 25 | 13.6% | 8.9% | ||
| Q2 25 | 11.4% | 7.0% | ||
| Q1 25 | 2.8% | -0.9% | ||
| Q4 24 | 21.0% | 13.6% | ||
| Q3 24 | 6.3% | 8.6% | ||
| Q2 24 | 18.7% | 9.7% | ||
| Q1 24 | 1.8% | 5.9% |
| Q4 25 | 3.0% | 2.6% | ||
| Q3 25 | 2.9% | 3.4% | ||
| Q2 25 | 2.4% | 3.3% | ||
| Q1 25 | 2.1% | 3.5% | ||
| Q4 24 | 3.5% | 4.4% | ||
| Q3 24 | 2.7% | 4.1% | ||
| Q2 24 | 2.0% | 4.4% | ||
| Q1 24 | 2.8% | 3.6% |
| Q4 25 | — | 6.70× | ||
| Q3 25 | 1.65× | 0.65× | ||
| Q2 25 | 1.52× | 1.47× | ||
| Q1 25 | 0.86× | 0.28× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 0.39× | 1.86× | ||
| Q2 24 | 1.70× | 1.91× | ||
| Q1 24 | 0.38× | 1.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OGN
Segment breakdown not available.
SEE
| Protective Segment | $1.1B | 78% |
| Other | $292.0M | 21% |
| Pension Plans Defined Benefit | $7.9M | 1% |
